Boston Scientific (BSX) Global Growth Robust, Macro Issues Ail

Boston Scientific (BSX) is gaining traction in the emerging markets. New regulatory approvals and accretive acquisitions bode well for its long-term growth. Yet, an unfavorable currency movement and macroeconomic concerns are major dampeners. The stock carries a Zacks Rank #3 (Hold) at present.BSX successfully continues with its expansion of operations across different geographies outside the United States. In 2022, 40% of the company’s consolidated revenues came from international regions.The company is al ...